Among the estate and succession-planning tools available to incorporated professionals, the family trust is arguably the most powerful. Structured correctly, it lets a pharmacist's family share in the wealth of the business, minimize taxes, and preserve flexibility across generations — while the pharmacist retains full control at the professional and regulatory levels. For a pharmacist, the family trust is not just a tax mechanism; it is a strategic ownership structure that coordinates corporate governance, ethical obligations, and intergenerational fairness.
What a family trust is
A trust is a legal relationship in which one person (the settlor) transfers property to another (the trustee) to hold for the benefit of others (the beneficiaries). The trust itself is neither a corporation nor an individual, but it is treated as a separate taxpayer under the Income Tax Act. The settlor creates the trust by contributing a nominal asset (often a $10 bill) and cannot later receive benefits. The trustees manage trust property in accordance with the deed and owe fiduciary duties to beneficiaries. The beneficiaries receive income or capital as the trustees determine. An optional appointor or protector holds power to add or remove trustees or amend administrative provisions. The trust deed sets the rules — what assets it may hold, how income is allocated, how long it can exist, and who benefits. Our broader family trusts guide covers the general Canadian framework.
Why pharmacists use them
Pharmacists use family trusts for five connected reasons. First, multiplying the LCGE: each individual who owns QSBC shares may claim up to $1.25 million in tax-free capital gains, and a trust that owns the shares can allocate the gain among multiple beneficiaries, each using their own exemption. Second, income splitting: although recent reforms limit dividend "sprinkling," trusts remain useful for distributing capital gains (still eligible for the LCGE) and dividends in limited circumstances, such as to adult family members active in the business. Third, estate-freeze integration: trusts are ideal recipients of new growth shares in a freeze, capturing future appreciation while the owner retains control via preferred shares. Fourth, asset protection: assets in trust are insulated from beneficiaries' creditors and marital claims. Fifth, flexibility: trustees may decide later who receives what, adjusting to changing family or tax circumstances.
How the multiplication works
The book's basic example makes the arithmetic concrete. A pharmacist owns a corporation worth $3 million and sets up a family trust whose beneficiaries include her spouse and two adult children. The trust subscribes for new common shares during an estate freeze. Five years later the corporation is sold for $3 million. The trust allocates the capital gain equally among the three beneficiaries, each claiming the $1.25 million LCGE, and the entire $3 million gain is tax-free. Without the trust, the owner alone could claim only one exemption, and roughly $700,000 in tax would have been payable. The same structure recurs throughout the book's sale examples — the family trust is the lever that turns a single exemption into several.
Pharmacy-specific ownership constraints
Because pharmacy corporations are professional corporations, they are subject to strict provincial College ownership rules, and those rules shape how a trust can be used. In Ontario and British Columbia, only pharmacists may hold voting shares, so a trust must hold non-voting shares and voting control must remain with licensed pharmacists. In Alberta and the Prairie provinces, pharmacist majority control is required and at least one trustee should be a pharmacist. In Quebec, only licensed pharmacists may own a pharmacy, and family trusts are typically ineligible as shareholders. The practical rule is simple: a trust can own non-voting, growth shares, but voting control must remain in licensed hands (see our glossary entry on voting and non-voting pharmacy shares).
Designing the trust deed
A pharmacist's trust deed must reflect both tax law and professional regulation. Essential clauses include a purpose clause stating that trust property may include professional-corporation shares only to the extent the applicable College permits; a trustee-eligibility clause requiring at least one trustee to be a licensed pharmacist while the trust holds pharmacy shares; discretionary distribution powers allowing trustees to allocate income or capital to any beneficiary in any proportion; an incapacity clause authorizing an attorney under the pharmacist's Power of Attorney to act as trustee or appointor if the pharmacist is incapacitated; a 21-year-rule clause providing mechanisms (such as a transfer to a new trust or to beneficiaries) to avoid a deemed disposition at the 21-year mark; and a conflict-of-interest provision preventing self-dealing. Optional clauses include an appointor clause to replace trustees, a protector clause for neutral oversight, and a spendthrift provision.
Administration, attribution, and the 21-year rule
Family trusts must maintain the same documentation standard as corporations: annual trustee resolutions allocating income or capital, financial statements and T3 returns, trust minutes recording decisions, share registers, and beneficiary-designation records. A trust must file a T3 return annually if it has income, taxable capital gains, or has made distributions, and since 2023 new rules require beneficial-ownership disclosure — the names, addresses, dates of birth, and tax numbers of all trustees, beneficiaries, and settlors. The attribution rules are the central trap: if the settlor retains control or personally benefits, income can be attributed back to them, which is why an independent settlor and clear separation are essential. And every 21 years a trust is deemed to dispose of its property at FMV, triggering potential capital gains; plan for this by rolling assets to a new trust or distributing shares to beneficiaries before the anniversary. The book's common-pitfalls table is a useful checklist: a trust holding voting shares contrary to College rules risks loss of the permit; trustees who are all non-pharmacists breach the control requirement; failing to file the T3 or beneficial-ownership disclosure risks CRA penalties and loss of the LCGE; a settlor who is also a beneficiary causes attribution; no 21-year plan produces a large deemed-disposition tax bill; and undocumented resolutions can cause the CRA to deny distributions.
Integrating the trust with the corporate structure
A trust can subscribe for shares at incorporation, ensuring flexibility from day one. The ideal stage to create one, however, is during an estate freeze: the pharmacist exchanges existing shares for fixed-value preferred shares, the trust subscribes for new growth shares for a nominal amount, and future appreciation accrues in the trust. Where a Holdco owns non-operating assets, the trust can hold Holdco shares rather than PPC shares, isolating risk. And when the Holdco receives life-insurance proceeds, it can pay tax-free capital dividends to the trust through its CDA, allowing distribution to beneficiaries.
The multi-LCGE sale, illustrated
The book's case study follows a pharmacist whose practice is worth $4 million and who, with his spouse, established a family trust years earlier with their three adult children as beneficiaries. The trust holds non-voting growth shares while the pharmacist retains voting preferred shares. When a national chain offers $4 million, he confirms QSBC status through purification, distributes shares from the trust to his spouse and children before the sale, and each family member claims a $1.25 million LCGE. Sale proceeds are paid through the Holdco, and the CDA credit is distributed tax-free. The entire $4 million gain is sheltered, the tax saving exceeds $900,000, and the family retains control of the Holdco and reinvests in new ventures. The trust multiplied the exemption, enabled flexibility, and turned a tax liability into a tax-free family legacy.
Ethics and family dynamics
Beyond taxation, a family trust carries real implications for family relationships, and the book is candid about them. Transparency matters: explaining the intent to all adult beneficiaries prevents the suspicion that secrecy breeds. Fairness matters: balancing control and benefit is especially delicate when some children work in the business and others do not, or when some are pharmacists eligible to hold voting shares and some are not. Trustee integrity matters: trustees should be appointed for judgment and fairness, not merely for blood relation, and major decisions are often made subject to majority or unanimous approval to avoid conflict. The trust is not a vehicle for favouritism or control — it is a framework for stewardship, and it works best when the family understands what it is meant to accomplish.
An implementation checklist
The book sets out a working checklist for putting a pharmacist's family trust in place: engage tax and legal professionals to draft a compliant trust deed; use an independent settlor to avoid attribution; appoint at least one pharmacist trustee to satisfy regulatory compliance while the trust holds pharmacy shares; restrict the trust to non-voting shares to satisfy College rules; maintain a detailed trust minute book to preserve LCGE eligibility; file the annual T3 return and beneficial-ownership disclosures to avoid CRA penalties; review the 21-year-anniversary plan to prevent an unexpected deemed disposition; integrate the trust with any estate freeze and Holdco so growth is captured efficiently; coordinate the trust with the Powers of Attorney and wills to ensure continuity on incapacity; and communicate the intent to the family to maintain harmony. Treated as an ongoing structure rather than a one-time filing, the trust remains both compliant and useful across decades.
A family trust transforms personal effort into family legacy, converts tax rules into opportunity, and turns succession into stewardship. Designed and maintained properly — with professional trustees, compliant ownership, and transparent communication — it multiplies both a family's wealth and the owner's peace of mind. Trusts are not loopholes; they are instruments of responsible, ethical planning.
This guide draws on Dale Barrett's book "Tax-Wise Estate Planning for Pharmacists" (Barrett Publishing). It is general information about Canadian tax and estate-planning concepts, not legal, tax, or accounting advice; pharmacy ownership rules vary by province and by College, so confirm the current rules and obtain professional advice before acting.